| abstract |
The present disclosure generally provides non-naturally-occurring polynucleotide sequences that facilitate high-level expression of one or more gene products (e.g., polypeptides, RNA) of interest in Neisseria meningitidis . Methods of use of such sequences, e.g., use in vaccine production, are also provided. |